Surveillance of High-Risk Group May Downstage Pancreatic Cancer

WEDNESDAY, July 20, 2022 -- Surveillance of high-risk individuals may downstage pancreatic ductal adenocarcinoma (PDAC), according to a study published online June 15 in the Journal of Clinical Oncology.
Mohamad Dbouk, M.D., from the Sol Goldman...

Source: Drugs.com - Pharma News - July 20, 2022 Category: Pharmaceuticals Source Type: news